What is the current share price of Zydus Lifesciences Limited (ZYDUSLIFE)?

As of the latest market update, Zydus Lifesciences Limited (ZYDUSLIFE) is trading at ₹1,150.8. The stock has moved 0.71% down in the recent session.

What is the technical sentiment for ZYDUSLIFE stock?

Based on our proprietary technical analysis, the current signal for ZYDUSLIFE is "BUY". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Zydus Lifesciences Limited?

Zydus Lifesciences Limited has seen a 52-week high of ₹1,181.5 and a 52-week low of ₹835.5. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Zydus Lifesciences Limited belong to?

Zydus Lifesciences Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of ZYDUSLIFE?

Zydus Lifesciences Limited (ZYDUSLIFE) has a market capitalization of approximately ₹1.16L Cr. This classifies it as a large cap stock in the Indian market.

ZYDUSLIFE

NSEF&O

Zydus Lifesciences Limited (LARGE CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹1,150.80

8.20 (0.71%)

Medium VOLATILITY

As on 10 Jul 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹1.16L Cr

LARGE CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

23.0

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹835.5+37.7%

52W High₹1,181.5-2.6%

Current Price

₹1,150.80

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹920.64

Upper Circuit₹1,380.96

Reference Price

₹1,150.80

Investment Checklist

Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1190.7

Ascending Channel on 1D — target ₹1185.32

Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))

SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))

Technical Analysis

Analysis from 2026-07-10

Confidence

80%

Trend

BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20

1116.57

EMA50

1064.91

EMA200

990.78

Price Action

MIXED

NEUTRAL

Higher Highs5

Higher Lows6

Lower Highs4

Lower Lows3

Support & Resistance Levels

Resistance (Above)

No recent resistance detected

Support (Below)

₹1117.65

₹1094.38

₹1053.92

₹1029.50

₹1016.40

Volume Analysis

TrendSTABLE

Change+7.30%

Unusual VolumeNo

Stop Loss Levels

Fixed Risk

1% Risk₹1139.29

3% Risk₹1116.28

5% Risk₹1093.26

7% Risk (Custom)

₹1070.24

Technical Levels

1x ATR (Volatility)₹1124.86

2x ATR (Swing)₹1098.92

3x ATR (Trend)₹1072.98

Immediate Support₹1117.65

Moving Averages

EMA 9 (Short-term)₹1138.25

EMA 20 (Medium-term)₹1116.57

EMA 50 (Trend)₹1064.91

EMA 200 (Long-term)₹990.78

Financials

Financial Analysis

Metric	Dec '24	Mar '25	Jun '25	Dec '25
Revenue	₹5,123.5 Cr	₹6,290.2 Cr	₹6,467 Cr	₹6,780.4 Cr
Net Profit	₹1,023.5 Cr	₹1,170.9 Cr	₹1,466.8 Cr	₹1,042.1 Cr
EPS	₹10.17	—	₹14.58	₹10.36
Operating Profit	₹1,445.1 Cr	₹1,914.1 Cr	₹2,243.4 Cr	₹1,842.9 Cr

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change	P/E Ratio	Market Cap
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,935.50	-0.17%	40.2	₹4.64L Cr large Cap
DIVISLAB	Divi's Laboratories Limited	₹6,836.00	+0.34%	70.4	₹1.81L Cr large Cap
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,901.50	+0.07%	77.5	₹1.66L Cr large Cap
CIPLA	Cipla Limited	₹1,439.40	-0.13%	30.1	₹1.16L Cr large Cap
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,150.80	-0.71%	23.0	₹1.16L Cr large Cap
LUPIN	Lupin Limited	₹2,496.30	-0.28%	21.4	₹1.14L Cr mid Cap
MANKIND	Mankind Pharma Limited	₹2,525.10	-0.27%	54.3	₹1.04L Cr mid Cap
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,244.30	-1.99%	25.6	₹1.04L Cr large Cap
AUROPHARMA	Aurobindo Pharma Limited	₹1,564.70	-1.43%	26.1	₹90.88K Cr mid Cap
LAURUSLABS	Laurus Labs Limited	₹1,537.80	+2.02%	91.5	₹83.02K Cr mid Cap
BIOCON	Biocon Limited	₹418.50	+3.70%	177.4	₹67.83K Cr mid Cap

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
29 May 2026	Buy Back	BUYBACK
25 Jul 2025	Dividend - Rs 11 Per Share	DIVIDEND
26 Jul 2024	Dividend - Rs 3 Per Share	DIVIDEND
23 Feb 2024	Buy Back	BUYBACK
28 Jul 2023	Dividend - Rs 6 Per Share	DIVIDEND

Announcements

Latest updates

View All

Date	Description	Link
10 Jul 2026	Shareholders meeting
09 Jul 2026	Copy of Newspaper Publication
08 Jul 2026	Certificate under SEBI (Depositories and Participants) Regulations, 2018
04 Jul 2026	Copy of Newspaper Publication
03 Jul 2026	Press Release

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
19 May 2026	Buyback
19 May 2026	Financial Results/Dividend
19 May 2026	Board Meeting Intimation	XBRL
09 Feb 2026	Financial Results
09 Feb 2026	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for ZYDUSLIFE

View All

NEWS

positive

Business Standard - Markets 7d ago

Zydus partners with Guardant Health and Apollo Hospitals to introduce Shield MCD in India

Zydus Lifesciences and Guardant Health, Inc., a leading precision oncology company, have an exclusive agreement to make the Shield Multi-Cancer Detection (MCD) test available in India, for which Zydus has signed a Memorandum of Understanding (MoU) with Apollo Hospitals to offer the test in the territory.

APOLLOAPOLLOHOSPMEDANTAPRECISIONZYDUSLIFEAutomobile and Auto ComponentsCapital Goods

Read full story

Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection test

neutral

ET Markets - Industry 7d ago

Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection test

Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health. This innovative blood test can identify signals for multiple cancer types in individuals aged 45 and above. The collaboration aims to enhance early cancer detection and improve patient outcomes across the nation, making advanced screening more accessible.

APOLLOAPOLLOHOSPMEDANTAZYDUSLIFECapital GoodsHealthcare

Read full story

Zydus Lifesciences, Apollo Hospitals partner to expand access to multi-cancer blood test in India

positive

CNBC TV18 - Markets 7d ago

Zydus Lifesciences, Apollo Hospitals partner to expand access to multi-cancer blood test in India

Zydus Lifesciences and Apollo Hospitals partner to expand access to Shield Multi-Cancer Detection blood test in India, screening 10 common cancers.

APOLLOAPOLLOHOSPZYDUSLIFECapital GoodsHealthcare

Read full story

ZYDUSLIFE

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for ZYDUSLIFE

Zydus partners with Guardant Health and Apollo Hospitals to introduce Shield MCD in India

Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection test

Zydus Lifesciences, Apollo Hospitals partner to expand access to multi-cancer blood test in India

Frequently Asked Questions

What is the current share price of Zydus Lifesciences Limited (ZYDUSLIFE)?

What is the technical sentiment for ZYDUSLIFE stock?

What is the 52-week high and low for Zydus Lifesciences Limited?

Which sector does Zydus Lifesciences Limited belong to?

What is the market capitalization of ZYDUSLIFE?